We’ve completed more than 4,000 consecutive isolated mitral valve repairs without a perioperative death. Our team shares cultural and technical factors behind that achievement as well as persistent repair durability.
PRIMARY Trial Aims to Guide Choice of Percutaneous Vs. Surgical Repair of Degenerative Mitral Regurgitation
The new NIH-funded multicenter investigation will help determine which therapy — MitraClip or surgery — is better in which patient types.
Severe Atrial Functional Mitral Regurgitation: Study Presents Most Detailed Profile to Date
An underrecognized form of functional mitral regurgitation of atrial origin demands heightened attention due to higher risks of death and hospitalization for heart failure and lower intervention rates.
Perspectives on the 2020 ACC/AHA Guideline for Valvular Heart Disease: Focus on the Mitral Valve
Three of our valve disease experts reflect on notable changes and developments related to mitral valve disease in the new guideline update.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
For Success in Mitral Valve Repair, Follow These 10 Commandments
Repair is feasible in over 95% cases of mitral valve prolapse and yields better outcomes than replacement, provided that these best practices are followed.
No. 2 Medical Innovation for 2020: Expanded Use of Minimally Invasive Mitral Valve Surgery
Expanded use of minimally invasive mitral valve surgery will be the No. 2 most influential medical innovation for 2020, predict experts at Cleveland Clinic.
Mitral Valve Disease: When and How to Intervene?
It’s increasingly clear that there’s no good reason to delay surgical repair in patients with primary mitral valve disease and severe regurgitation. Two experts share perspectives about what that means in practice.
Imaging Mitral Regurgitation in Pursuit of Progression Predictors
Ischemic mitral regurgitation is extremely difficult to manage. That’s why Dr. Deborah Kwon is intent on identifying imaging-based predictors of progression to enable earlier and wiser intervention.
MitraClip Reaches Real-World Use in U.S., but Population Refinement Remains
This newly approved percutaneous therapy offers a minimally invasive option for mitral regurgitation patients at high risk from surgery. Ongoing studies aim to better define just which patients benefit.